The Market for Molecular Histology and Cytology (HPV, in situ hybridization, CTCs, Flow Cytometry)

The Market for Molecular Histology and Cytology (HPV, in situ hybridization, CTCs, Others)

In Situ Hybridization, HPV Testing, Circulating Tumor Cells and Flow Cytometry are important histology and cytology approaches to testing. In situ hybridization and more specifically fluorescent in situ hybridization (FISH) techniques use DNA probes to detect pathogens and molecular structures in cells. More recently flow cytometry techniques and other cell capture devices allow lab professionals to select targeted cells that can be further analyzed with PCR, sequencing and mass spectrometry.
The result so far has been gene patterns that help distinguish cell and tumor attributes that demonstrate the presence of disease as well as risk for disease progression and sensitivity to specific therapeutics. A growing population of cancer patients has increased the number of histology analyses performed.

This Kalorama report contains market sizes and forecasts for these technologies, identifies drivers and market trends, and identifies the competitive situation in the market. Kalorama's analysis is the result of detailed research into secondary literature and primary interviews to develop reliable business planning information for entrants or investors in this market. Over 25 Company profiles are included as part of the research in this report.